Share: Facebook Twitter GooglePLus LinkedIn
Activity Provided By:

Medical Learning Institute

Acute Coronary Syndrome: Getting to the Heart of the Matter for Pharmacists

Access Activity

Overview / Abstract:

This activity is accredited for health-system pharmacists and pharmacy technicians that manage patients with Acute Coronary Syndrome (ACS).

Educational Objectives

Upon completion of this activity, the participant will be able to:


• Identify patients at risk for ACS
• Explain the distinct phases of the continuum of IHD and ACS: UA, NSTEMI, and STEMI in order to assist the care team in managing patients as they progress through treatment
• Review recent advances in treatment for the ACS/CAD patient to optimize outcomes
• Summarize best practices to counsel patients on the importance of adherence and follow-up care while monitoring their ongoing health including coordinating all their prescriptions

Pharmacy Technician

• Explain the risk factors of ACS
• Describe the differences between UA, NSTEMI and STEMI
• Identify recent developments in the management of ACS
• Recognize the importance of supporting patient information, adherence and outcomes


Jun 18, 2019


Pharmacy CPE



Credits / Hours

Pharmacists and Pharmacy Technicians / 1.0 Contact Hour (0.1 CEU)



Presenters / Authors / Faculty

Toby C. Trujillo, PharmD, FCCP, FAHA, BCPS-AQ Cardiology

Activity Specialities / Related Topics

Cardiology / Cardiovascular

Sponsors / Supporters / Grant Providers

This activity is provided by Medical Learning Institute, Inc.

This activity is supported by an educational grant from AstraZeneca.

Keywords / Search Terms

Medical Learning Institute Medical Learning Institute,ACS, Acute Coronary Syndrome,Cardiology,Trujillo,Free CE,UA,NSTEMI,STEMI Free CE CME

Access Activity

RXinsider,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps. RXinsider,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the Terms of Service. Site Map.